Paper
8 March 1995 Photodynamic therapy with photofrin II derivative in the treatment of carcinosarcoma of rats with diabetes mellitus
Vasile F. Dima, Virgil V. Vasiliu, Mircea D. Ionescu, Dezideriu Laky
Author Affiliations +
Proceedings Volume 2461, ROMOPTO '94: Fourth Conference in Optics; (1995) https://doi.org/10.1117/12.203586
Event: ROMOPTO '94: 4th Conference on Optics, 1994, Bucharest, Romania
Abstract
Four batches of Wistar rats with Walker-256 carcinosarcoma were used to test the effects of PDT upon `in vivo' tumor growth. Ten days after tumor transplantation, rats from batch I(DM) were exposed to Photofrin II (20 mg/kg), given i.p. 24 h before exposure to laser (632.8 nm; 10 mw; He-Ne laser), five doses given at 4 days intervals; batch II and batch III received sole treatment (DM or PDT). The control batch IV included animals with untreated Walker-256 tumors. The animals were followed up 42 days.
© (1995) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Vasile F. Dima, Virgil V. Vasiliu, Mircea D. Ionescu, and Dezideriu Laky "Photodynamic therapy with photofrin II derivative in the treatment of carcinosarcoma of rats with diabetes mellitus", Proc. SPIE 2461, ROMOPTO '94: Fourth Conference in Optics, (8 March 1995); https://doi.org/10.1117/12.203586
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Tumors

Photodynamic therapy

Photomicroscopy

Helium neon lasers

In vivo imaging

Oxygen

Transplantation

Back to Top